ITRM20030442A1 - Composizione farmaceutica (stressen) per il trattamento di iperomocisteinemia. - Google Patents

Composizione farmaceutica (stressen) per il trattamento di iperomocisteinemia.

Info

Publication number
ITRM20030442A1
ITRM20030442A1 IT000442A ITRM20030442A ITRM20030442A1 IT RM20030442 A1 ITRM20030442 A1 IT RM20030442A1 IT 000442 A IT000442 A IT 000442A IT RM20030442 A ITRM20030442 A IT RM20030442A IT RM20030442 A1 ITRM20030442 A1 IT RM20030442A1
Authority
IT
Italy
Prior art keywords
treatment
pharmaceutical composition
stressen
hyperomocisteinemia
hyperhomocysteinemia
Prior art date
Application number
IT000442A
Other languages
English (en)
Inventor
Sergio Anzalone
Original Assignee
Medosan Ind Biochimiche Riuni Te S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medosan Ind Biochimiche Riuni Te S R L filed Critical Medosan Ind Biochimiche Riuni Te S R L
Priority to IT000442A priority Critical patent/ITRM20030442A1/it
Publication of ITRM20030442A0 publication Critical patent/ITRM20030442A0/it
Priority to AT04104599T priority patent/ATE395055T1/de
Priority to DE602004013695T priority patent/DE602004013695D1/de
Priority to EP04104599A priority patent/EP1518554B1/en
Publication of ITRM20030442A1 publication Critical patent/ITRM20030442A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT000442A 2003-09-26 2003-09-26 Composizione farmaceutica (stressen) per il trattamento di iperomocisteinemia. ITRM20030442A1 (it)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IT000442A ITRM20030442A1 (it) 2003-09-26 2003-09-26 Composizione farmaceutica (stressen) per il trattamento di iperomocisteinemia.
AT04104599T ATE395055T1 (de) 2003-09-26 2004-09-22 Pharmazeutische zusammensetzung zur behandlung von hyperhomocysteinämie
DE602004013695T DE602004013695D1 (de) 2003-09-26 2004-09-22 Pharmazeutische Zusammensetzung zur Behandlung von Hyperhomocysteinämie
EP04104599A EP1518554B1 (en) 2003-09-26 2004-09-22 Pharmaceutical composition for the treatment of hyperhomocysteinemia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000442A ITRM20030442A1 (it) 2003-09-26 2003-09-26 Composizione farmaceutica (stressen) per il trattamento di iperomocisteinemia.

Publications (2)

Publication Number Publication Date
ITRM20030442A0 ITRM20030442A0 (it) 2003-09-26
ITRM20030442A1 true ITRM20030442A1 (it) 2005-03-27

Family

ID=30131588

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000442A ITRM20030442A1 (it) 2003-09-26 2003-09-26 Composizione farmaceutica (stressen) per il trattamento di iperomocisteinemia.

Country Status (4)

Country Link
EP (1) EP1518554B1 (it)
AT (1) ATE395055T1 (it)
DE (1) DE602004013695D1 (it)
IT (1) ITRM20030442A1 (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20110847A1 (it) * 2011-05-13 2012-11-14 Soldato Piero Del Uso di un composto solforato per il trattamento di iperomocisteinemia e patologie correlate
CN105560264A (zh) * 2016-03-11 2016-05-11 广东伊茗药业有限公司 一种含腺苷钴胺的组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054128A (en) * 1997-09-29 2000-04-25 Wakat; Diane Dietary supplements for the cardiovascular system
DE10004651A1 (de) * 2000-02-03 2001-08-16 Jutta Dierkes Kombination von blutdrucksenkenden Wirkstoffen mit Wirkstoffen, die den Homocysteinspiegel zu senken vermögen
US20030054978A1 (en) * 2001-08-31 2003-03-20 Babish John G. Arginine compositions for coordinate modification of multiple cardiovascular risk factors
DE10206159A1 (de) * 2002-02-14 2003-08-28 Kosmas Kg Mittel, enthaltend Folsäure, Vitamin B6 und Vitamin B12, und dessen Verwendung

Also Published As

Publication number Publication date
EP1518554B1 (en) 2008-05-14
ATE395055T1 (de) 2008-05-15
EP1518554A1 (en) 2005-03-30
DE602004013695D1 (de) 2008-06-26
ITRM20030442A0 (it) 2003-09-26

Similar Documents

Publication Publication Date Title
BR0316350A (pt) Diaminotriazóis úteis como inibidores de proteìna cinases
IS8062A (is) 2,4-dí(fenýlamínó)pýrimídín sem eru gagnleg í meðhöndlun æxlissjúkdóma, bólgusjúkdóma og ónæmiskerfissjúkdóma
SE0203713D0 (sv) Novel compounds
ECSP095220A (es) Derivados de n-fenil-2-pirimidin-amina
SE0200979D0 (sv) New compounds
ATE372767T1 (de) Dpp-iv-hemmer
PL372809A1 (en) Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
IS2517B (is) Notkun á setnum 2-amínótetralínum í fyrirbyggjandi meðferð á Parkinsons-veiki
EA200501333A1 (ru) 5,7-ДИАМИНОПИРАЗОЛО[4,3-d]ПИРИМИДИНЫ, ПОЛЕЗНЫЕ ПРИ ЛЕЧЕНИИ ГИПЕРТЕНЗИИ
ATE464299T1 (de) Neues phenylalaninderivat
DE60327745D1 (de) Verwendung von adapalen zur behandlung dermatologischer erkrankungen
EA200401114A2 (ru) Замещённые гидроксиэтиламины
DK1789398T3 (da) 2-amino-quinazolin derivater anvendelige som inhibitorer af B-sekretase (BACE)
DK1767535T3 (da) Syntese af epothiloner, mellemprodukter deraf, analoge og deres anvendelse
IL176111A0 (en) 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri
PL1809288T3 (pl) Zastosowanie pochodnych 1,4-bis-(3-aminoalkilo)piperazyny do leczenia chorób neurodegeneracyjnych
EA200700901A1 (ru) Производные 2-амидо-4-фенилтиазола, их получение и применение в терапии
UY28098A1 (es) Derivados de anilinopirazol útiles en el tratamiento de la diabetes
EA200700400A1 (ru) Производные n-(1h-индолил)-1н-индол-2-карбоксамидов, их получение и их применение в терапии
HN2003000038A (es) Esteres hidroxamato de acido n-(4-fenil-sustituido)-antranilico
ATE450498T1 (de) Cycloalken-dicarbonsäure-verbindungen als entzündungshemmende, immunmodulatorische und antiproliferative mittel
EA200501557A1 (ru) Новый способ синтеза (2s)-индолин-2-карбоновой кислоты и использование в синтезе периндоприла
ITRM20030442A1 (it) Composizione farmaceutica (stressen) per il trattamento di iperomocisteinemia.
UY27475A1 (es) Amidas de ácido piperazinciclohexanocarboxílico sustituidas y su utilización
DOP2003000766A (es) Derivados de anilinopirazol utiles en el tratamiento de la diabetes